# Ultrasound IPP to Predict Response to Medical Therapy in LUTS/BPH

> **NCT07306767** · — · COMPLETED · sponsor: **Ain Shams University** · enrollment: 130 (actual)

## Conditions studied

- Benign Prostatic Hyperplasia
- Lower Urinary Tract Symptoms
- Bladder Outlet Obstruction

## Interventions

- **DIAGNOSTIC_TEST:** Transabdominal ultrasound measurement of intravesical prostatic protrusion
- **DRUG:** Alpha-adrenergic blocker
- **DRUG:** 5-alpha reductase inhibitor

## Key facts

- **NCT ID:** NCT07306767
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-12-30
- **Primary completion:** 2025-09-30
- **Final completion:** 2025-09-30
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2025-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07306767

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07306767, "Ultrasound IPP to Predict Response to Medical Therapy in LUTS/BPH". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07306767. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*